INMB Announces Amended Material Transfer Agreement with Anthony Nolan to Expand CORDStrom™ MSC Platform for RDEB, Oncology, Inflammatory Diseases
INmune Bio Inc. Common stock · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $1.39
+9.1% in 7d after detection
Post-detection moves
1h
—
1d
-1.3%
3d
-7.1%
7d
+9.1%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS